drugset / Trial / NCT06082557

A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

NCT06082557 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is an open-labeled, single-arm, multiple-dose escalation and single-dose expansion clinical study of cell therapy to observe and evaluate the safety and efficacy of T60c injection in the treatment of patients with advanced solid tumors

Timeline

Start
2023-10
Primary completion
2025-03
Completion
2025-06

Drugs

EvaluationDrugModalityDoseRoute
Subject T60c Cell therapy — Intravenous

Indications